R. Aguayo

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.

S. Lee, P. Krogstad, S. Nachman, 2000, AIDS research and human retroviruses.

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

P. Krogstad, S. Nachman, J. Mcnamara, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.